Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Makoto Ishii and Naoki Hasegawa.
Connection Strength

3.037
  1. Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study. J Infect. 2020 11; 81(5):e3-e5.
    View in: PubMed
    Score: 0.226
  2. Sitafloxacin-Containing Regimen for the Treatment of Refractory Mycobacterium avium Complex Lung Disease. Open Forum Infect Dis. 2019 Apr; 6(4):ofz108.
    View in: PubMed
    Score: 0.203
  3. Development of lung cancer in patients with nontuberculous mycobacterial lung disease. Respir Investig. 2019 Mar; 57(2):157-164.
    View in: PubMed
    Score: 0.200
  4. Quantitative assessment of erector spinae muscles in patients with Mycobacterium avium complex lung disease. Respir Med. 2018 12; 145:66-72.
    View in: PubMed
    Score: 0.198
  5. Perfusion Defect-Concordant Progression of Unilateral Refractory Pulmonary Mycobacterium avium Complex Disease. Am J Respir Crit Care Med. 2018 09 15; 198(6):803-804.
    View in: PubMed
    Score: 0.196
  6. Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease. BMC Pulm Med. 2018 Jul 13; 18(1):114.
    View in: PubMed
    Score: 0.194
  7. Aspergillus precipitating antibody in patients with Mycobacterium avium complex lung disease: A cross-sectional study. Respir Med. 2018 05; 138:1-6.
    View in: PubMed
    Score: 0.190
  8. Natural history of Mycobacterium fortuitum pulmonary infection presenting with migratory infiltrates: a case report with microbiological analysis. BMC Infect Dis. 2018 01 02; 18(1):1.
    View in: PubMed
    Score: 0.187
  9. Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease. BMC Pulm Med. 2017 Dec 13; 17(1):198.
    View in: PubMed
    Score: 0.186
  10. Clinical characteristics of pulmonary Mycobacterium lentiflavum disease in adult patients. Int J Infect Dis. 2018 Feb; 67:65-69.
    View in: PubMed
    Score: 0.186
  11. The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases. BMC Infect Dis. 2017 08 09; 17(1):558.
    View in: PubMed
    Score: 0.182
  12. Impact of cavity and infiltration on pulmonary function and health-related quality of life in pulmonary Mycobacterium avium complex disease: A 3-dimensional computed tomographic analysis. Respir Med. 2017 05; 126:9-16.
    View in: PubMed
    Score: 0.177
  13. COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease. Clin Exp Rheumatol. 2021 May-Jun; 39(3):631-638.
    View in: PubMed
    Score: 0.059
  14. The real-time reverse transcription-polymerase chain reaction threshold cycle values for severe acute respiratory syndrome coronavirus 2 predict the prognosis of coronavirus disease 2019 pneumonia. Respir Investig. 2021 May; 59(3):360-363.
    View in: PubMed
    Score: 0.058
  15. Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2. J Clin Pathol. 2021 01; 74(1):67-68.
    View in: PubMed
    Score: 0.056
  16. Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports. Medicine (Baltimore). 2020 Aug 28; 99(35):e21804.
    View in: PubMed
    Score: 0.056
  17. Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus. Ann Rheum Dis. 2021 05; 80(5):e77.
    View in: PubMed
    Score: 0.056
  18. Acute onset olfactory/taste disorders are associated with a high viral burden in mild or asymptomatic SARS-CoV-2 infections. Int J Infect Dis. 2020 Oct; 99:19-22.
    View in: PubMed
    Score: 0.056
  19. Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice. Biochem Biophys Res Commun. 2019 05 28; 513(2):405-411.
    View in: PubMed
    Score: 0.051
  20. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease. J Infect Chemother. 2019 Mar; 25(3):218-221.
    View in: PubMed
    Score: 0.049
  21. Sphingosine 1-phosphate receptor modulator ONO-4641 stimulates CD11b+Gr-1+ cell expansion and inhibits lymphocyte infiltration in the lungs to ameliorate murine pulmonary emphysema. Mucosal Immunol. 2018 11; 11(6):1606-1620.
    View in: PubMed
    Score: 0.049
  22. Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia. PLoS Pathog. 2018 04; 14(4):e1006955.
    View in: PubMed
    Score: 0.048
  23. Anti-inflammatory roles of mesenchymal stromal cells during acute Streptococcus pneumoniae pulmonary infection in mice. Cytotherapy. 2018 03; 20(3):302-313.
    View in: PubMed
    Score: 0.047
  24. Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation. BMC Pulm Med. 2017 Sep 07; 17(1):123.
    View in: PubMed
    Score: 0.046
  25. Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease. Clin Infect Dis. 2017 Jul 15; 65(2):244-251.
    View in: PubMed
    Score: 0.045
  26. Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium. Mediators Inflamm. 2013; 2013:264260.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.